APA

Balogh G. A., Mailo D., Nardi H., Corte M. M., Vincent E., Barutta E., Lizarraga G., Lizarraga P., Montero H. & Gentili R. (2010). Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients. : Experimental and therapeutic medicine.

Chicago

Balogh Gabriela A, Mailo Daniel, Nardi Hector, Corte Maria Marta, Vincent Esteban, Barutta Elena, Lizarraga Guillermo, Lizarraga Pablo, Montero Hector and Gentili Roberto. 2010. Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients. : Experimental and therapeutic medicine.

Harvard

Balogh G. A., Mailo D., Nardi H., Corte M. M., Vincent E., Barutta E., Lizarraga G., Lizarraga P., Montero H. and Gentili R. (2010). Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients. : Experimental and therapeutic medicine.

MLA

Balogh Gabriela A, Mailo Daniel, Nardi Hector, Corte Maria Marta, Vincent Esteban, Barutta Elena, Lizarraga Guillermo, Lizarraga Pablo, Montero Hector and Gentili Roberto. Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients. : Experimental and therapeutic medicine. 2010.